Search results for "Brea"

showing 10 items of 4298 documents

Expression Levels and Clinical-Pathological Correlations of HER2/neu in Primary and Metastatic Human Breast Cancer

2005

In this retrospective study we assessed the expression of the HER2/neu oncogene product in a series of 574 consecutive breast cancer cases, all recruited at the Maurizio Ascoli Cancer Center of Civico Hospital, in Palermo, between January 1998 and June 2003. The HER2/neu expression was evaluated using immunohistochemistry and scored from 0 to +3 as per FDA recommendations. The HER2/neu expression levels were related to the clinical-pathological features of the disease, including tumor size, nodal and menopausal status, estrogen and progesterone receptors, and hormonal or chemotherapeutic treatment. In 108 patients with a follow-up period of 3 years or more, the HER2/neu expression was also …

AdultOncologymedicine.medical_specialtyTime FactorsReceptor ErbB-2medicine.drug_classBreast NeoplasmsDisease-Free SurvivalGeneral Biochemistry Genetics and Molecular BiologyHER2/neuBreast cancerHistory and Philosophy of ScienceInternal medicineBiomarkers TumormedicineHumansNeoplasm Metastasisskin and connective tissue diseasesPathologicalIn Situ Hybridization FluorescenceAgedRetrospective StudiesbiologyOncogenebusiness.industryGeneral NeuroscienceCancerRetrospective cohort studyMiddle Agedmedicine.diseaseImmunohistochemistryGene Expression Regulation NeoplasticTreatment OutcomeEstrogenLymphatic Metastasisbiology.proteinImmunohistochemistryFemalebusinessAnnals of the New York Academy of Sciences
researchProduct

Solid variant of mammary "adenoid cystic carcinoma with basaloid features" merging with "small cell carcinoma"

2005

We describe a rare case of a solid variant of a mammary adenoid cystic carcinoma with basaloid features (sbACC) and its coexistence with a "small cell" carcinoma (SCC), identified and confirmed by histological and immunohistochemical observations: the absence of glandular structures and PAS-positive globules, positivity for neuroendocrine markers (NSE, synaptophysin and chromogranin), and negativity for 34betaE12 and SMA actin were the aspects suggesting the presence of SCC. Furthermore, positivity for CD10 was found both in sbA CC and in SCC, supporting the hypothesis that the two components share the same histogenetic myoepithelial origin and represent an example of dedifferentiation alon…

AdultPathologymedicine.medical_specialtyAdenoid cystic carcinoma2734Breast NeoplasmsBiologyHistogenesisSettore MED/08 - Anatomia PatologicaMastectomy SegmentalSmall-cell carcinomaPathology and Forensic MedicineNeoplasms Multiple PrimaryBiomarkers TumormedicineCarcinomaHumansBreastCarcinoma Small CellneoplasmsSmall cell carcinomaMyoepithelial cellChromogranin ABasaloid adenoid cystic carcinomaCell BiologyPeriodic Acid-Schiff Reactionmedicine.diseaseCarcinoma Adenoid CysticImmunohistochemistrystomatognathic diseasesSettore MED/18 - Chirurgia GeneraleCarcinoma Basal CellChemotherapy AdjuvantAxillaSynaptophysinbiology.proteinLymph Node ExcisionImmunohistochemistryFemaleBasaloid adenoid cystic carcinoma; Breast; Small cell carcinoma; Adult; Axilla; Biomarkers Tumor; Breast Neoplasms; Carcinoma Adenoid Cystic; Carcinoma Basal Cell; Carcinoma Small Cell; Chemotherapy Adjuvant; Female; Humans; Immunohistochemistry; Lymph Node Excision; Mastectomy Segmental; Neoplasms Multiple Primary; Periodic Acid-Schiff Reaction; 2734Breast NeoplasmHuman
researchProduct

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors

2012

The purpose of this study was to prospectively evaluate the relationship between tumor blood flow and glucose metabolism as evaluated by dynamic first-pass (18)F-FDG PET and by proliferation and endothelial pathologic markers in the setting of newly diagnosed breast cancer.Forty patients were prospectively included. Biopsy samples of each tumor were used to assess the Ki67 index of proliferation and immunostaining for CD34 (a panendothelial cell marker) and CD105 (a proliferation-related endothelial cell marker). All patients underwent (18)F-FDG PET/CT at least 1 wk after sample biopsy and before any treatment. A dynamic 2-min acquisition was performed immediately after intravenous injectio…

AdultPathologymedicine.medical_specialtyAngiogenesisStandardized uptake valueBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineMultimodal Imaging030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicineNeovascularization03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18BiopsymedicineBiomarkers Tumor[INFO.INFO-IM]Computer Science [cs]/Medical ImagingHumansRadiology Nuclear Medicine and imagingProspective StudiesComputingMilieux_MISCELLANEOUSAgedCell Proliferationmedicine.diagnostic_testNeovascularization Pathologicbusiness.industryEndothelial CellsBlood flowEndoglinMiddle Agedmedicine.diseasePrognosisLogistic ModelsPositron emission tomography030220 oncology & carcinogenesisPositron-Emission TomographyBlood CirculationFemalemedicine.symptombusinessTomography X-Ray Computed
researchProduct

Mucoepidermoid mammary carcinoma. Immunohistochemical and biochemical analyses of intermediate filaments.

1989

The histological features of mucoepidermoid mammary carcinomas (MMCs) are presented, and criteria for distinguishing these tumours from squamous epithelial metaplasia in other mammary carcinomas are considered. Immunohistochemical and gel-electrophoretic analyses of the intermediate-filament proteins in one MMC case revealed a complex pattern of cytokeratin polypeptide expression. The simple-epithelium-type cytokeratins 7, 8, 18, and 19 were detected mainly in nonsquamous (including mucinous) cells, while the stratified-epithelium-type cytokeratins 5, 6, 14, 16, and 17 were present in squamous cells. However, in both the nonsquamous and squamous regions of the tumour, cytokeratins of the "r…

AdultPathologymedicine.medical_specialtyIntermediate FilamentsBreast NeoplasmsHistogenesisBiologyMalignancyPathology and Forensic MedicineMetastasisCytokeratinGlial Fibrillary Acidic ProteinmedicineCarcinomaHumansVimentinMolecular BiologyAgedAged 80 and overEpitheliomaCarcinomaCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistrySquamous metaplasiaEpithelial MetaplasiaKeratinsFemaleVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial aty…

2009

It is essential to reach a better understanding of "flat epithelial atypia/columnar cell lesions" (FEA/CCLs) in breast core biopsies. Our aim was to explore their biological nature, in order to predict the likelihood of an upgrade to carcinoma. "Cytological grading" has been specially focused, in view of its possible utility in the choice of management. One hundred thirty of a total of 900 cases core needle (CN)/vacuum-assisted biopsies (VABs), with diagnoses of "hyperplasia" and "atypia" were retrospectively re-evaluated. Pathological findings of further excision biopsies (FEBs) performed in 40/75 patients with follow-up were compared with the previous diagnoses. In all cases, both Ki-67 a…

AdultPathologymedicine.medical_specialtyPhysiologyBiopsyClinical Biochemistrycolumnar cell lesionc-kit expressionSettore MED/08 - Anatomia PatologicaBiopsyCarcinomamedicineAtypiaHumansBreastPathologicalGrading (tumors)Agedmedicine.diagnostic_testbiologybusiness.industryAntibodies MonoclonalEpithelial CellsCell BiologyMiddle AgedHyperplasiamedicine.diseaseImmunohistochemistryProto-Oncogene Proteins c-kitKi-67 Antigenflat epithelial atypiaKi-67biology.proteinImmunohistochemistryFemalecytological gradingbusiness
researchProduct

Imunohistochemical Demonstration of Carcinoembryonic Antigen (CEA) in 120 Mammary Carcinomas and its Correlation with Tumor Type, Grading, Staging Pl…

1985

Antisera to CEA were used for the immunohistochemical localization and quantification of this antigen in 120 Bouin-fixed, paraffin embedded mammary carcinomas. These results were compared to tumor type, grading, staging, biochemical receptor status, cytosolic CEA-levels of the same tumors, and preoperative plasma CEA-levels. Mammary carcinomas were usually characterized by a low percentage of CEA-positive tumor cells: 50.9% of the cases contained more than 5% CEA-positive tumor cells and were therefore defined as being CEA-histopositive in this study. A relation could be shown between CEA-histopositivity and the histologic tumor type. The majority of invasive lobular carcinomas, tubular, an…

AdultPathologymedicine.medical_specialtyReceptor Statusendocrine system diseasesBreast NeoplasmsPathology and Forensic MedicineImmunoenzyme TechniquesCarcinoembryonic antigenAntigenAntigens NeoplasmmedicineCarcinomaHumansneoplasmsEstrogen Receptor StatusGrading (tumors)Agedbiologybusiness.industryCarcinomaCell BiologyMiddle Agedmedicine.diseasedigestive system diseasesCarcinoembryonic AntigenCarcinoma Intraductal NoninfiltratingReceptors EstrogenInvasive lobular carcinomabiology.proteinImmunohistochemistryFemalebusinessPathology - Research and Practice
researchProduct

Perinatal and newborn care in a two years retrospective study in a first level peripheral hospital in Sicily (Italy)

2019

Abstract Background Two hundred seventy-five thousand maternal deaths, 2.7 million neonatal deaths, and 2.6 million stillbirths have been estimated in 2015 worldwide, almost all in low-income countries (LICs). Moreover, more than 20 million severe disabilities result from the complications of pregnancy, childbirth or its management each year. A significant decrease of mortality/morbidity rates could be achieved by providing effective perinatal and newborn care also in high-income countries (HICs), especially in peripheral hospitals and/or rural areas, where the number of childbirths per year is often under the minimal threshold recognized by the reference legislation. We report on a 2 years…

AdultPatient Transfermedicine.medical_specialtyComplications of pregnancyAdolescentTerm BirthCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansChildbirth030212 general & internal medicineRetrospective StudiesPerinatal mortalityPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsResearchPublic healthInfant NewbornQuality of carelcsh:RJ1-570Gestational agelcsh:PediatricsRetrospective cohort studyMiddle AgedStillbirthDelivery ObstetricNewbornmedicine.diseaseInfant FormulaObstetric Labor ComplicationsPerinatal CareBreast FeedingItalyPremature BirthFemaleMaternal deathbusinessItalian Journal of Pediatrics
researchProduct

Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study.

2013

Breast cancer survivors may experience adverse effects of cancer and/or treatment years after completion of therapy, which can considerably decrease quality of life (QoL). Little is known about the time course of QoL in breast cancer survivors beyond the fifth year post-diagnosis, when routine follow-up care has usually terminated. We therefore explored in detail whether and to what extent restrictions in breast cancer survivors persist and whether changes or aggravations in QoL occurred over time.QoL was assessed 1, 3, 5, and 10 years post-diagnosis in a population-based cohort of initially 387 female breast cancer patients from Saarland (Germany), using the EORTC QLQ-C30 and QLQ-BR23. Tim…

AdultPediatricsmedicine.medical_specialtyAdolescentCross-sectional studyPopulationBreast NeoplasmsYoung AdultBreast cancerAge DistributionQuality of lifemedicineHumansRadiology Nuclear Medicine and imagingLongitudinal StudiesSurvivorsYoung adultAdverse effecteducationAgededucation.field_of_studybusiness.industryCancersocial sciencesHematologyGeneral MedicineMiddle Agedmedicine.diseasehumanitiesCross-Sectional StudiesOncologyCohortQuality of LifeFemalebusinessActa oncologica (Stockholm, Sweden)
researchProduct

Variations in breastfeeding rates for very preterm infants between regions and neonatal units in Europe: results from the MOSAIC cohort

2010

Abstract: Objectives To compare breastfeeding rates at discharge for very preterm infants between European regions and neonatal units, and to identify characteristics associated with breast feeding using multilevel models. Methods Population-based cohort of 3006 very preterm births (2231 weeks of gestation) discharged home from neonatal units in eight European regions in 2003. Results Breastfeeding rates varied from 19% in Burgundy to 70% in Lazio, and were correlated with national rates in the entire newborn population. Women were more likely to breast feed if they were older, primiparous and European; more premature, smaller and multiple babies or those with bronchopulmonary dysplasia wer…

AdultPediatricsmedicine.medical_specialtyBreastfeedingGestational AgeCohort StudiesYoung AdultIntensive careHumansMedicineBronchopulmonary DysplasiaPregnancybusiness.industryObstetricsAge FactorsInfant NewbornObstetrics and GynecologyGestational ageGeneral Medicinemedicine.diseaseEuropeParityBreast FeedingBronchopulmonary dysplasiaPediatrics Perinatology and Child HealthCohortIntensive Care NeonatalFemaleHuman medicinebusinessBreast feedingInfant PrematureCohort studyArchives of Disease in Childhood - Fetal and Neonatal Edition
researchProduct

Trait-specific tracking and determinants of body composition: a 7-year follow-up study of pubertal growth in girls

2008

Abstract Background Understanding how bone (BM), lean (LM) and fat mass (FM) develop through childhood, puberty and adolescence is vital since it holds key information regarding current and future health. Our study aimed to determine how BM, LM and FM track from prepuberty to early adulthood in girls and what factors are associated with intra- and inter-individual variation in these three tissues. Methods The study was a 7-year longitudinal cohort study. BM, LM and FM measured using dual-energy X-ray absorptiometry, self-reported dietary information, leisure time physical activity (LTPA) and other factors were assessed one to eight times in 396 girls aged 10 to 13 years (baseline), and in 2…

AdultPercentilemedicine.medical_specialtyBone densityAdolescentPhysiologyMotherslcsh:MedicineMotor ActivityDiet SurveysCohort StudiesAbsorptiometry PhotonBone DensityPrepubertyInternal medicinemedicineHumansParent-Child RelationsChildMedicine(all)business.industrySiblingsBody WeightPubertylcsh:RGeneral MedicineHeritabilityMiddle AgedPedigreeEndocrinologyQuartileLean body massFemalebusinessBreast feedingCohort studyFollow-Up StudiesResearch ArticleBMC Medicine
researchProduct